市場調査レポート
商品コード
1387451
強直性脊椎炎治療市場レポート:2030年までの動向、予測、競合分析Ankylosing Spondylitis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
強直性脊椎炎治療市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年11月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
強直性脊椎炎治療の動向と予測
世界の強直性脊椎炎治療市場は、2024年から2030年までのCAGRが6.5%で、2030年までに推定84億米ドルに達すると予測されます。この市場の主な促進要因は、強直性脊椎炎の罹患率の上昇、疾患に対する認識と診断の高まり、強直性脊椎炎治療の進歩です。世界の強直性脊椎炎治療市場の将来は、病院薬局、小売薬局、オンライン薬局の各市場における機会によって有望視されています。
強直性脊椎炎治療市場の洞察
Lucintelの予測では、強直性脊椎炎の成長により、予測期間中はNSAIDsが引き続き大きなセグメントとなります。
同市場では、小売薬局の数が増加しており、患者にとって利用しやすいことから、小売薬局が引き続き最大セグメントとなります。
北米は、高齢者人口の増加と政府の支援策により、予測期間中最大の地域であり続けると思われます。
Ankylosing Spondylitis Treatment Trends and Forecast
The future of the global ankylosing spondylitis treatment market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global ankylosing spondylitis treatment market is expected to reach an estimated $8.4 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising occurence of ankylosing spondylitis, growing awareness and diagnosis of condition, and advancement in ankylosing spondylitis therapy.
A more than 150-page report is developed to help in your business decisions.
Ankylosing Spondylitis Treatment by Segment
The study includes a forecast for the global ankylosing spondylitis treatment by drug class, distribution channel, and region.
Ankylosing Spondylitis Treatment Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:
Ankylosing Spondylitis Treatment Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
Ankylosing Spondylitis Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Ankylosing Spondylitis Treatment Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ankylosing spondylitis treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ankylosing spondylitis treatment companies profiled in this report include-
Ankylosing Spondylitis Treatment Market Insights
Lucintel forecasts that NSAIDs will remain the larger segment over the forecast period due to growth of ankylosing spondylitis.
Within this market, retail pharmacy will remain the largest segment due to growing number of retail pharmacies and it is easy to reach for patients.
North America will remain the largest region over the forecast period due to growth of geriatric population and supportive government initiatives.
Features of the Global Ankylosing Spondylitis Treatment Market
Market Size Estimates: Ankylosing spondylitis treatment market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Ankylosing spondylitis treatment market size by drug class, distribution channel, and region in terms of value ($B).
Regional Analysis: Ankylosing spondylitis treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different drug classes, distribution channels, and regions for the ankylosing spondylitis treatment market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ankylosing spondylitis treatment market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the ankylosing spondylitis treatment market size?
Answer: The global ankylosing spondylitis treatment market is expected to reach an estimated $8.4 billion by 2030.
Q2. What is the growth forecast for ankylosing spondylitis treatment market?
Answer: The global ankylosing spondylitis treatment market is expected to grow with a CAGR of 6.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the ankylosing spondylitis treatment market?
Answer: The major drivers for this market are rising occurence of ankylosing spondylitis, growing awareness and diagnosis of condition, and advancement in ankylosing spondylitis therapy.
Q4. What are the major segments for ankylosing spondylitis treatment market?
Answer: The future of the ankylosing spondylitis treatment market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.
Q5. Who are the key ankylosing spondylitis treatment market companies?
Answer: Some of the key ankylosing spondylitis treatment companies are as follows:
Q6. Which ankylosing spondylitis treatment market segment will be the largest in future?
Answer: Lucintel forecasts that NSAIDs will remain the larger segment over the forecast period due to growth of ankylosing spondylitis.
Q7. In ankylosing spondylitis treatment market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to growth of geriatric population and supportive government initiatives.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.